Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria

Journal of Peptide Science

Volumn 16, Issue 11, 2010, Pages 607-612

  Taira, Junichi ^a,b   Kida, Yutaka ^a   Yamaguchi, Hiroshi ^b   Kuwano, Koichi ^a   Higashimoto, Yuichiro ^a   Kodama, Hiroaki ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Aib; Amphiphilicity; Antibiotic resistant bacteria; Antimicrobial peptide; Membrane permeation

Indexed keywords

ALANINE; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; ARGININE; CATION; PROTEINASE;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CHEMICAL MODIFICATION; CHEMICAL PHENOMENA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS;

AMINOISOBUTYRIC ACIDS; ANTIMICROBIAL CATIONIC PEPTIDES; CATIONS; CELL MEMBRANE PERMEABILITY; DRUG DESIGN; ESCHERICHIA COLI; LIPID BILAYERS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; SURFACE-ACTIVE AGENTS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS;

EID: 78650443242     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1270     Document Type: Article

References (32)

1. Wang G, Li X, Wang Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res. 2009; 37: 933-937.
2. Woolley GA, Wallace BA. Model ion channels: gramicidin and alamethicin. J. Membr. Biol. 1992; 129: 109-136.
3. Sansom MSP. The biophysics of peptide models of ion channels. Prog. Biophys. Mol. Biol. 1991; 55: 139-235.
4. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005; 3: 238-250.
5. Shai Y. Molecular recognition between membrane-spanning polypeptides. Trends. Biochem. Sci. 1995; 20: 460-464.
6. Nakajima Y, Alvarez-Bravo J, Cho J, Homma K, Kanegasaki S, Natori S. Chemotherapeutic activity of synthetic antimicrobial peptides: correlation between chemotherapeutic activity and neutrophil-activating activity. FEBS Lett. 1997; 415: 64-66.
7. Alvarez-Bravo J, Kurata S, Natori S. Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus. Biochem. J. 1994; 302: 535-538.
8. Fernandez-Lopez S, Kim HS, Choi EC, Delgado M, Granja JR, Khasanov A, Kraehenbuehl K, Long G, Weinberger DA, Wilcoxen KM, Ghadiri MR. Antibacterial agents based on the cyclic D, L-α-peptide architecture. Nature 2001; 412: 452-455.
9. Higashimoto Y, Kodama H, Jelokhani-Niaraki M, Kato F, Kondo M. Structure-function relationship of model Aib-containing peptides as ion transfer intermembrane templates. J. Biochem. 1999; 125: 705-712.
10. Yamaguchi H, Kodama H, Osada S, Jelokhani-Niaraki M, Kato F, Kondo M. The position of Aib residues defines the antimicrobial activity of Aib-containing peptides. Bull. Chem. Soc. Jpn. 2002; 75: 1563-1568.
11. Taira J, Furukawa S, Hatakeyama T, Aoyagi H, Kodama H. Modifications of hydrophobic value and hydrophobic moment value of cationic model peptides for conversion of peptide-membrane interactions. Bull. Chem. Soc. Jpn. 2008; 81: 733-739.
12. Zikou S, Koukkou AI, Mastora P, Sakarellos-Daitsiotis M, Sakarellos C, Drainas C, Panou-Pomonis E. Design and synthesis of cationic Aib-containing antimicrobial peptides: conformational and biological studies. J. Pept. Sci. 2007; 13: 481-486.
13. Yamaguchi H, Kodama H, Osada S, Kato F, Jelokhani-Niaraki M, Kondo M. Effect of α, α-dialkyl amino acids on the protease resistance of peptides. Biosci. Biotechnol. Biochem. 2003; 67: 2269-2272.
14. Whitmore L, Chugh JK, Snook CF, Wallace BA. The peptaibol database: a sequence and structure resource. J. Pept. Sci. 2003; 9: 663-665.
15. Dorschner RA, Lopez-Garcia B, Peschel A, Kraus D, Morikawa K, Nizet V, Gallo RL. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB. J. 2006; 20: 35-42.
16. Taira J, Jelokhani-Niaraki M, Osada S, Kato F, Kodama H. Ion-channel formation assisted by electrostatic interhelical interactions in covalently dimerized amphiphilic helical peptides. Biochemistry 2008; 47: 3705-3714.
17. Chen YH, Yang JT, Martinez HM. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 1972; 11: 4120-4131.
18. Burgess AW, Leach SJ. An obligatory alpha-helical amino acid residue. Biopolymers 1973; 12: 2599-2605.
19. Dathe M, Wieprecht T, Nikolenko H, Handel L, Maloy WL, MacDonald DL, Beyermann M, Bienert M. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett. 1997; 403: 208-212.
20. Dathe M, Schumann M, Wieprecht T, Winkler A, Beyermann M, Krause E, Matsuzaki K, Murase O, Bienert M. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 1996; 35: 12612-12622.
21. Tang M, Waring AJ, Hong M. Phosphate-mediated arginine insertion into lipid membranes and pore formation by cationic membrane peptide from solid-state NMR. J. Am. Chem. Soc. 2007; 129: 11438-11446.
22. Kida Y, Higashimoto Y, Inoue H, Shimizu T, Kuwano K. A novel secreted protease from Pseudomonas aeruginosa activates NF-κB through protease-activated receptors. Cell Microbiol. 2008; 10: 1491-1504.
23. Hamamoto K, Kida Y, Zhang Y, Shimizu T, Kuwano K. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol. Immunol. 2002; 46: 741-749.
24. Schmidtchen A, Frick IM, Andersson E, Tapper H, Björck L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 2002; 46: 157-168.
25. Belas R, Manos J, Suvanasuthi R. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 2004; 72: 5159-5167.
26. De Zotti M, Biondi B, Formaggio F, Toniolo C, Stella L, Park Y, Hahm KS. Trichogin GA IV: an antibacterial and protease-resistant peptide. J. Pept. Sci. 2009; 15: 615-619.
27. Agawa Y, Lee S, Ono S, Aoyagi H, Ohno M, Taniguchi T, Anzai K, Kirino Y. Interaction with phospholipid bilayers, ion channel formation, and antimicrobial activity of basic amphipathic α-helical model peptides of various chain lengths. J. Biol. Chem. 1991; 266: 20218-20222.
28. Otvos L Jr. Antibacterial peptides and proteins with multiple cellular targets. J. Pept. Sci. 2005; 11: 697-706.
29. McPhee JB, Hancock REW. Function and therapeutic potential of host defence peptides. J. Pept. Sci. 2005; 11: 677-687.
30. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, Nagaoka I. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2002; 106: 20-26.
31. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jornvall H, Wigzell H, Gudmundsson GH. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96: 3086-3093.
32. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, Hancock REW, Speert DP. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 2004; 172: 1146-1156.